Custom Market Research
Answer Your Top Market Access Questions
- Launch Pricing and Contracting Strategy: Custom research that helps brands understand payer pricing expectations, contracting thresholds, and access requirements ahead of launch.
- Impact of New Entrants: Primary payer and IDN research designed to evaluate how new competitors affect formulary placement, utilization management, and coverage decision‑making.
- Loss of Exclusivity (LOE) Planning: Expert-led analysis to assess access risk, payer behavior, and generic or biosimilar uptake as brands plan for and navigate LOE.
- Customizable, access-focused research design: MMIT combines our industry-leading panel with market access experts to answer brand‑specific access questions across the product lifecycle.
Understand How Payers Respond to Your Brand Messaging
What Our Clients Are Saying
"For rare diseases, traditional labs and claims data alone haven’t given us the depth we need to act. Norstella’s EMR data is changing that. The level of clarity is redefining how we go to market."
Director, Commercial and Medical IT, Rare Disease
Global Biotech Company
"For rare diseases, traditional labs and claims data alone haven’t given us the depth we need to act. Norstella’s EMR data is changing that. The level of clarity is redefining how we go to market."
Director, Commercial and Medical IT, Rare Disease
Global Biotech Company
"For rare diseases, traditional labs and claims data alone haven’t given us the depth we need to act. Norstella’s EMR data is changing that. The level of clarity is redefining how we go to market."
Director, Commercial and Medical IT, Rare Disease
Global Biotech Company
"For rare diseases, traditional labs and claims data alone haven’t given us the depth we need to act. Norstella’s EMR data is changing that. The level of clarity is redefining how we go to market."
Director, Commercial and Medical IT, Rare Disease
Global Biotech Company
How We Can Help
MMIT’s Custom Market Research delivers targeted market access insights when strategies matter most—at launch, during competitive disruption, and ahead of loss of exclusivity. By combining our industry-leading panel with market access experts, we help brands understand coverage decision‑making and act with confidence in a changing access landscape.
Custom Market Research delivers tailored insights aligned to your specific business challenges—such as pricing, coverage, competition, and lifecycle strategy—so you can address the questions that matter most to your brand.
Through primary qualitative and quantitative research MMIT uncovers real‑world perspectives on coverage decisions, access barriers, and treatment dynamics.
By coupling our industry-leading panel with market access expertise, Custom Market Research provides decision‑ready intelligence that helps teams anticipate risk, validate strategies, and act with confidence.
Key Insights From MMIT
Improving Access with Market Research Insights
In this ebook, see how nine different manufacturers have partnered with MMIT on qualitative and quantitative custom market research.
Strategies for Early Market Access Planning
This webinar details how and why manufacturers benefit from early market research, using client use cases to show how planning for potential access scenarios leads to greater utilization at launch.
Mobilizing Data for Product Launch Success
Learn how one small biopharma company achieved 95% payer coverage for its rare disease therapy using MMIT’s strategic data solutions.
Solutions to Support Your Strategy
Enhance your custom research with related solutions, which offer swift access to payer and IDN decision-makers, timely and actionable feedback, and real-time visibility into treatment patterns, payer dynamics, and access trends. These benefits empower your team to move from insight to confident, informed action.
Rapid Response
Improve your brand strategy with Rapid Response’s quick, actionable answers to key business questions among a representative sample of the payer and IDN stakeholders that you care about.